1. Home
  2. MYSZ vs CERO Comparison

MYSZ vs CERO Comparison

Compare MYSZ & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYSZ
  • CERO
  • Stock Information
  • Founded
  • MYSZ 1999
  • CERO 2017
  • Country
  • MYSZ Israel
  • CERO United States
  • Employees
  • MYSZ N/A
  • CERO N/A
  • Industry
  • MYSZ Computer Software: Prepackaged Software
  • CERO
  • Sector
  • MYSZ Technology
  • CERO
  • Exchange
  • MYSZ Nasdaq
  • CERO Nasdaq
  • Market Cap
  • MYSZ 4.0M
  • CERO 3.5M
  • IPO Year
  • MYSZ N/A
  • CERO N/A
  • Fundamental
  • Price
  • MYSZ $1.28
  • CERO $8.06
  • Analyst Decision
  • MYSZ Strong Buy
  • CERO Strong Buy
  • Analyst Count
  • MYSZ 1
  • CERO 2
  • Target Price
  • MYSZ $3.00
  • CERO $45.00
  • AVG Volume (30 Days)
  • MYSZ 191.5K
  • CERO 62.9K
  • Earning Date
  • MYSZ 08-19-2025
  • CERO 08-22-2025
  • Dividend Yield
  • MYSZ N/A
  • CERO N/A
  • EPS Growth
  • MYSZ N/A
  • CERO N/A
  • EPS
  • MYSZ N/A
  • CERO N/A
  • Revenue
  • MYSZ $6,752,000.00
  • CERO N/A
  • Revenue This Year
  • MYSZ $29.71
  • CERO N/A
  • Revenue Next Year
  • MYSZ N/A
  • CERO N/A
  • P/E Ratio
  • MYSZ N/A
  • CERO N/A
  • Revenue Growth
  • MYSZ N/A
  • CERO N/A
  • 52 Week Low
  • MYSZ $1.01
  • CERO $6.71
  • 52 Week High
  • MYSZ $9.40
  • CERO $895.40
  • Technical
  • Relative Strength Index (RSI)
  • MYSZ 49.32
  • CERO 47.60
  • Support Level
  • MYSZ $1.18
  • CERO $7.80
  • Resistance Level
  • MYSZ $1.32
  • CERO $8.09
  • Average True Range (ATR)
  • MYSZ 0.10
  • CERO 0.43
  • MACD
  • MYSZ -0.00
  • CERO 0.13
  • Stochastic Oscillator
  • MYSZ 18.83
  • CERO 91.17

About MYSZ My Size Inc.

My Size Inc is a USA-based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers and licensing cloud-enabled software subscriptions, associated software maintenance, and support.

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.

Share on Social Networks: